Autotransfusion Systems Market Size is Projected to Reach US$ 466.8 Million by 2033| Fact.MR
The autotransfusion systems is expected to reach US$ 315.4 million in 2023 and grow at a compound annual growth rate (CAGR) of 4% between 2023 and 2033, according to the most recent industry analysis conducted by market research and competitive intelligence company Fact.MR.During a particular surgical procedure, a piece of medical technology called an autotransfusion system collects and processes the patient's blood, obviating the need for external blood transfusions. This gadget's novel operating architecture makes it possible for it to provide vital autologous blood during a variety of device applications.
The rising number of surgical procedures, such as liver or other organ transplant surgeries, is expected to fuel sales growth throughout the forecast period and increase demand for autotransfusion systems.
๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐จ๐ฉ๐ฒ ๐จ๐ ๐๐ก๐ข๐ฌ ๐๐๐ฉ๐จ๐ซ๐ญ:
https://www.factmr.com/connectus/sample?flag=S&rep_id=8327
By 2033, the autotransfusion systems market is projected to grow to a value of US$ 466.8 million worldwide.
Over the estimated timeframe, the Chinese market is expected to grow at a high compound annual growth rate of 4%.
Over the next ten years, the demand for autotransfusion products is predicted to grow at a CAGR of 4.5%.
Over the course of the projected period, autotransfusion accessory sales are expected to grow at a 3% CAGR.
"There is high demand for autotransfusion systems from hospitals due to rising rate of patient intake for getting advanced treatment procedures," says a Fact.MR analyst.
๐๐๐๐๐ง๐ญ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฏ๐๐ฅ๐จ๐ฉ๐ฆ๐๐ง๐ญ๐ฌ
In November 2021, Fresenius SE & Co. KGaA and Omnicell, Inc. partnered to offer hospitals and health systems in the United States state-of-the-art innovative pharmacy technology.
ProCell, the first medical device developed by ProCell Surgical Inc. to effectively automate the labor-intensive and obsolete surgical sponge-blood recovery procedure for intraoperative autotransfusion, was unveiled in June 2020.
๐๐๐ญ ๐๐ฎ๐ฌ๐ญ๐จ๐ฆ๐ข๐ณ๐๐ญ๐ข๐จ๐ง ๐จ๐ง ๐ญ๐ก๐ข๐ฌ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐จ๐ซ ๐๐ฉ๐๐๐ข๐๐ข๐ ๐๐๐ฌ๐๐๐ซ๐๐ก ๐๐จ๐ฅ๐ฎ๐ญ๐ข๐จ๐ง๐ฌ:
https://www.factmr.com/connectus/sample?flag=RC&rep_id=8327
๐๐จ๐ฆ๐ฉ๐๐ญ๐ข๐ญ๐ข๐ฏ๐ ๐๐๐ง๐๐ฌ๐๐๐ฉ๐
To increase revenue, a number of autotransfusion system suppliers are implementing a variety of marketing techniques, including joint ventures, partnerships, local sourcing, raising the bar for their products, and more.
LivaNova holds a leading position in the industry for autotransfusion systems. LivaNova's cardiovascular product line includes cutting-edge autotransfusion devices. The business is recognized as a world leader in autotransfusion because of its experience and commitment to researching innovative solutions. LivaNova's most advanced, user-friendly, and powerful ATS system, XTRA, has been supporting doctors since 2010. It blends cutting-edge technology capabilities with powerful performance and user-friendliness. XTRA has reduced the risks associated with allogeneic transfusion and shortened hospital stays for over a million patients.
Fresenius is a leading brand in the autotransfusion systems market. Fresenius Kabi, a subsidiary of the business, offers a comprehensive range of autotransfusion devices. CATSmart is a new continuous red cell separation method based on continuous flow technology that Fresenius Kabi developed for recycling blood intra- and post-cardiac, orthopedic, or vascular procedures. The only autotransfusion system available on the market, CATSmart, uses a continuous flow approach to guarantee consistent quality red blood cells (RBCs) that are accessible quickly whenever needed.
Haemonetics has carved out a significant niche for itself in the market for autotransfusion systems. The organization provides a large selection of blood, plasma, and whole blood products. Hospitals may recover and redistribute a patient's high-quality blood after medium to high blood loss procedures, including cardiac, orthopedic, trauma, transplant, vascular, and OBGYN surgeries, by utilizing the company's Cell Saver Elite technology.
๐๐๐ซ๐ค๐๐ญ ๐ ๐ซ๐จ๐ง๐ญ๐ซ๐ฎ๐ง๐ง๐๐ซ๐ฌ
Atrium Medical Corporation (A Part of Getinge Group)
Becton, Dickinson and Company
Beijing ZKSK Technology Co., Ltd.
Braile Biomรฉdica
Fresenius Medical Care AG & Co. KGaA
Gen World Medical Devices
Haemonetics Corporation
Livanova PLC
Medtronic PLC
Redax
๐๐๐๐๐ง๐ญ ๐๐๐ฏ๐๐ฅ๐จ๐ฉ๐ฆ๐๐ง๐ญ๐ฌ
Cardiovascular diseases rank among the world's top causes of death. It is believed that the accumulation of cholesterol and other chemicals in the coronary arteries is the cause of many coronary artery diseases (CAD).
The National Center for Biotechnology Information (NCBI) estimates that 5.8 million people in the US and over 23 million people globally suffer from heart failure.
Therefore, the growing number of heart-related procedures is fueling the demand for autotransfusion devices. The growing use of autologous blood transfusion in significant orthopedic and cardiovascular procedures is anticipated to drive market expansion in the North America region over the forecast period, along with the existence of a developed healthcare infrastructure.
Due to the constantly increasing rates of trauma and accidents in nations like Germany, France, and the United Kingdom as well as the strong emphasis on implementing intraoperative and postoperative cell salvage methods, Europe is expected to offer substantial growth potential for market competitors.
๐๐จ๐ง๐ญ๐๐๐ญ:
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232
Email: sales@factmr.com
๐๐๐จ๐ฎ๐ญ ๐ ๐๐๐ญ.๐๐
We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Autotransfusion Systems Market Size is Projected to Reach US$ 466.8 Million by 2033| Fact.MR here
News-ID: 3470972 • Views: โฆ
More Releases from Fact.MR
Craft Spirit Market Anticipates $ 59.47 Billion Valuation by 2034, Driven by 29% โฆ
According to the most recent market analysis conducted by knowledgeable analysts at Fact.MR, the size of the worldwide craft spirit market is estimated to be worth US$ 20.5 billion in 2023 and is expected to grow at a CAGR of 29% to reach a valuation of US$ 230 billion by the end of 2033.
Craft spirits are growing in popularity because of their exceptional flavor, quality, and distinctiveness. The craft spiritsโฆ
Bank Kiosk Market Forecasted to Expand Rapidly, Projecting US$ 80 Billion Value โฆ
A recent analysis by knowledgeable experts at Fact.MR values the worldwide bank kiosk market at US$ 18.5 billion in 2023 and projects it will grow at a CAGR of 15% to reach US$ 80 billion by the end of 2033.
An automated self-service device called a bank kiosk offers customers a range of banking services without the need for human support. A vital component of the contemporary banking infrastructure, bank kiosksโฆ
Smart Badges Market To Witness Exponential Growth, Expected to Hit US$ 50 Billio โฆ
The smart badge market is expected to grow at a remarkable compound annual growth rate (CAGR) of 9% from 2023 to 2033, from its estimated valuation of US$ 21 billion in 2023 to US$ 50 billion by 2033.
An electrical gadget with an embedded memory or microcontroller in the shape of a touch pad is called a smart badge. It establishes a connection with a reader by short-range wireless connectivity orโฆ
Pod Vapes Market Is Forecasted To Increase At A CAGR Of 12.5% By 2033: Fact.MR R โฆ
The global pod vape market, valued at USD 2.52 billion in 2023, is projected to grow significantly, reaching USD 8.18 billion by 2033. This expansion represents a compound annual growth rate (CAGR) of 12.5% over the decade.
The Pod Vape Industry sales study offers a comprehensive analysis on diverse features including production capacities, Pod Vape demand, product developments, sales revenue generation and Pod Vape market outlook across the globe.
market research reportโฆ
More Releases for Fresenius
What's driving the Dialyzers Market Growth? Prominent Players: Baxter Internatio โฆ
The rising incidence of chronic renal failures is anticipated to create lucrative growth opportunities for the global dialyzers market, finds Fortune Business Insights in their new study. The study is titled, โDialyzers Market: Global Market Analysis, Insights, and Forecasts, 2019 โ 2026.โ According to the study, the market will rise at a CAGR of 4.9% and reach a value of US$ 13707.2 Mn by the end of 2026 as againstโฆ
Oncology Nutrition Market Competitive Analysis 2023: Nestle, Danone, Abbott, Fre โฆ
Global Oncology Nutrition Market to reach USD 2.7 billion by 2025.
While preparing this Oncology Nutrition market research report, few of the attributes that have been adopted include highest level of spirit, practical solutions, committed research and analysis, innovation, integrated approaches, and most up-to-date technology. With the watchful use of established and advanced tools such as SWOT analysis and Porter's Five Forces Analysis, this market report has been structured. Every possibleโฆ
Oncology Nutrition Market Competitive Analysis 2023: Nestle, Danone, Abbott, Fre โฆ
Global Oncology Nutrition Market to reach USD 2.7 billion by 2025.
While preparing this Oncology Nutrition market research report, few of the attributes that have been adopted include highest level of spirit, practical solutions, committed research and analysis, innovation, integrated approaches, and most up-to-date technology. With the watchful use of established and advanced tools such as SWOT analysis and Porter's Five Forces Analysis, this market report has been structured. Every possibleโฆ
Global Continuous Renal Replacement Therapy Market 2018 - Fresenius, Baxter
Apex Market Reports, recently published a detailed market research study focused on the โContinuous Renal Replacement Therapy Marketโ across the global, regional and country level. The report provides 360ยฐ analysis of โContinuous Renal Replacement Therapy Marketโ from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and estimates the future trendโฆ
Blood Tubing Set Market: Top Players - Fresenius, Baxter, Nipro
MarketResearchReports.Biz adds โGlobal Blood Tubing Set Market Share, Size, Trends and Forecast Market Research Reportโ reports to its database. This report provides a strategic analysis of the Blood Tubing Set and the growth estimates for the forecasted period.
This report studies the Blood Tubing Set market status and outlook of global and major regions, from angles of manufacturers, regions, product types and end industries; this report analyzes the top manufacturers inโฆ
Global IV Equipment Market 2018 - Becton, Dickinson, Fresenius, Moog
Apex Market Reports, recently published a detailed market research study focused on the โIV Equipment Marketโ across the global, regional and country level. The report provides 360ยฐ analysis of โIV Equipment Marketโ from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and estimates the future trend of IV Equipment onโฆ